Detalhe da pesquisa
1.
Impact of isolated germline JAK2V617I mutation on human hematopoiesis.
Blood
; 121(20): 4156-65, 2013 May 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-23535062
2.
Limited duration of complete remission on ruxolitinib in myeloid neoplasms with PCM1-JAK2 and BCR-JAK2 fusion genes.
Ann Hematol
; 94(2): 233-8, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25260694
3.
Inactivation of polycomb repressive complex 2 components in myeloproliferative and myelodysplastic/myeloproliferative neoplasms.
Blood
; 119(5): 1208-13, 2012 Feb 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-22053108
4.
Response of ETV6-FLT3-positive myeloid/lymphoid neoplasm with eosinophilia to inhibitors of FMS-like tyrosine kinase 3.
Blood
; 118(8): 2239-42, 2011 Aug 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-21705501
5.
Developmental origins and impact of BCR-ABL1 fusion and IKZF1 deletions in monozygotic twins with Ph+ acute lymphoblastic leukemia.
Blood
; 118(20): 5559-64, 2011 Nov 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-21960589
6.
EZH2 mutational status predicts poor survival in myelofibrosis.
Blood
; 118(19): 5227-34, 2011 Nov 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-21921040
7.
Ponatinib as targeted therapy for FGFR1 fusions associated with the 8p11 myeloproliferative syndrome.
Haematologica
; 98(1): 103-6, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22875613
8.
Ruxolitinib as potential targeted therapy for patients with JAK2 rearrangements.
Haematologica
; 98(3): 404-8, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-22875628
9.
In search of the original leukemic clone in chronic myeloid leukemia patients in complete molecular remission after stem cell transplantation or imatinib.
Blood
; 116(8): 1329-35, 2010 Aug 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-20462961
10.
Immunologically silent cancer clone transmission from mother to offspring.
Proc Natl Acad Sci U S A
; 106(42): 17882-5, 2009 Oct 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-19822752
11.
Identification of FOXP1 and SNX2 as novel ABL1 fusion partners in acute lymphoblastic leukaemia.
Br J Haematol
; 153(1): 43-6, 2011 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-21391972
12.
Frequent CBL mutations associated with 11q acquired uniparental disomy in myeloproliferative neoplasms.
Blood
; 113(24): 6182-92, 2009 Jun 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-19387008
13.
Transcription factor mutations in myelodysplastic/myeloproliferative neoplasms.
Haematologica
; 95(9): 1473-80, 2010 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-20421268
14.
Screening for diverse PDGFRA or PDGFRB fusion genes is facilitated by generic quantitative reverse transcriptase polymerase chain reaction analysis.
Haematologica
; 95(5): 738-44, 2010 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-20107158
15.
Is cancer latency an outdated concept? Lessons from chronic myeloid leukemia.
Leukemia
; 34(9): 2279-2284, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32632094
16.
Mutational mechanisms of EZH2 inactivation in myeloid neoplasms.
Leukemia
; 34(12): 3206-3214, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32322039
17.
PRR14L mutations are associated with chromosome 22 acquired uniparental disomy, age-related clonal hematopoiesis and myeloid neoplasia.
Leukemia
; 33(5): 1184-1194, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30573780
18.
Megalencephaly syndromes: exome pipeline strategies for detecting low-level mosaic mutations.
PLoS One
; 9(1): e86940, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24497998
19.
Mosaic loss of chromosome Y in peripheral blood is associated with shorter survival and higher risk of cancer.
Nat Genet
; 46(6): 624-8, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24777449
20.
Recurrent CEP85L-PDGFRB fusion in patient with t(5;6) and imatinib-responsive myeloproliferative neoplasm with eosinophilia.
Leuk Lymphoma
; 54(7): 1527-31, 2013 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-23186533